Takeaway
- Patients with opioid use disorder being treated with buprenorphine had a sharp increase in opioid overdose risk during months when this treatment was interrupted by >15 consecutive days.
Why this matters
- Findings underscore the importance of ensuring treatment continuity.
Study design
- US longitudinal case-control study of 34,505 Medicare fee-for-service beneficiaries...
